| N06AX16 |
Venlafaxine |
DEPREXOR |
Tablet |
75 |
mg |
60 |
Софарма АД, България |
100 |
mg |
- |
29.76 |
0.39711 |
17.87 |
50% |
8.93 |
|
F31.3,F31.4,F31.5,F31.6,F31.7,F33.0,F33.1,F33.2,F33.3,F33.4 |
№40/27.08.2009; НСР-7552/19.11.2015 |
02.01.2016 |
08.09.2012 |
|
Заличен |
397 |
| N06AX16 |
Venlafaxine |
DEPREXOR |
Tablet |
37.5 |
mg |
60 |
Софарма АД, България |
100 |
mg |
- |
15.72 |
0.66756 |
15.02 |
50% |
7.51 |
|
F31.3,F31.4,F31.5,F31.6,F31.7,F33.0,F33.1,F33.2,F33.3,F33.4 |
№40/27.08.2009; КЦРР-901/28,06,2012 |
20.07.2012 |
08.09.2012 |
|
Заличен |
395 |
| N06AX16 |
Venlafaxine |
DEPREXOR |
Tablet |
75 |
mg |
30 |
Софарма АД, България |
100 |
mg |
- |
15.72 |
0.66756 |
15.02 |
50% |
7.51 |
|
F31.3,F31.4,F31.5,F31.6,F31.7,F33.0,F33.1,F33.2,F33.3,F33.4 |
№40/27.08.2009; КЦРР-901/28,06,2012 |
20.07.2012 |
08.09.2012 |
|
Заличен |
396 |
| N06AX16 |
Venlafaxine |
DEPREXOR |
Tablet |
37.5 |
mg |
30 |
Софарма АД, България |
100 |
mg |
- |
7.86 |
0.66756 |
7.51 |
50% |
3.76 |
|
F31.3,F31.4,F31.5,F31.6,F31.7,F33.0,F33.1,F33.2,F33.3,F33.4 |
№40/27.08.2009; КЦРР-901/28,06,2012 |
20.07.2012 |
08.09.2012 |
|
Заличен |
4012 |
| N06AX16 |
Venlafaxine |
Deprexor ER |
Prolonged release capsule, hard |
150 |
mg |
30 |
Софарма АД, България |
100 |
mg |
- |
7.01 |
0.15578 |
7.01 |
50% |
3.51 |
|
F31.3,F31.4,F31.5,F31.6,F31.7,F33.0,F33.1,F33.2,F33.3,F33.4 |
КЦРР-1610/05.11.2012 г.; НСР-986/16.08.2013.; НСР-6877/30.07.2015. |
02.09.2015 |
|
|
Заличен |
2047 |
| N06AX16 |
Venlafaxine |
Deprexor ER |
Prolonged release capsule, hard |
75 |
mg |
30 |
Софарма АД, България |
100 |
mg |
- |
3.58 |
0.15578 |
3.51 |
50% |
1.75 |
|
F31.3,F31.4,F31.5,F31.6,F31.7,F33.0,F33.1,F33.2,F33.3,F33.4 |
КЦРР-1610/05.11.2012 г.; НСР-985/16.08.2013; НСР-6467/18.06.2015 |
16.07.2015 |
|
|
Заличен |
2046 |
| N06AX16 |
Venlafaxine |
EFECTIN ER 150 |
Prolonged release capsule, hard |
150 |
mg |
28 |
Pfizer Europe MA EEIG, Белгия |
100 |
mg |
- |
23.65 |
0.35256 |
14.81 |
50% |
7.4 |
|
F31.3,F31.4,F31.5,F31.6,F31.7,F33.0,F33.1,F33.2,F33.3,F33.4 |
КЦРР-385/29.03.2012 г.; КЦРР-1461/02.10.2012 г.; КЦРР-2181/06.02.2013 г.; НСР-12833/26.05.2017; НСР-16586/24.08.2018; НСР-17431/06.12.2018 |
02.01.2019 |
08.09.2012 |
|
Активен |
1651 |
| N06AX16 |
Venlafaxine |
EFECTIN ER 75 |
Prolonged release capsule, hard |
75 |
mg |
28 |
Pfizer Europe MA EEIG, Белгия |
100 |
mg |
- |
13.09 |
0.35256 |
7.4 |
50% |
3.7 |
|
F31.3,F31.4,F31.5,F31.6,F31.7,F33.0,F33.1,F33.2,F33.3,F33.4 |
КЦРР-385/29.03.2012 г.; КЦРР-1461/02.10.2012 г.; КЦРР-2181/06.02.2013 г.; НСР-12834/26.05.2017; НСР-15687/17.05.2018; НСР-17431/06.12.2018 |
02.01.2019 |
08.09.2012 |
|
Активен |
1650 |
| N06AX16 |
Venlafaxine |
Efexiva |
Prolonged release capsule, hard |
150 |
mg |
30 |
Sandoz d.d., Словения |
100 |
mg |
- |
11.29 |
0.15578 |
7.01 |
50% |
3.51 |
|
F31.3,F31.4,F31.5,F31.6,F31.7,F33.0,F33.1,F33.2,F33.3,F33.4 |
№ 180/ 27.07.2011; КЦРР-2501/06.03.2013 г.; НСР-2129/14.12.2013; НСР-3620/29.05.2014 |
02.07.2014 |
08.09.2012 |
|
Заличен |
2361 |
| N06AX16 |
Venlafaxine |
Efexiva |
Prolonged release capsule, hard |
75 |
mg |
30 |
Sandoz d.d., Словения |
100 |
mg |
- |
11.29 |
0.15578 |
3.51 |
50% |
1.75 |
|
F31.3,F31.4,F31.5,F31.6,F31.7,F33.0,F33.1,F33.2,F33.3,F33.4 |
№ 180/ 27.07.2011; КЦРР-672/30.05.2012 г.; КЦРР-2500/06.03.2013 г.; НСР-2129/14.12.2013; НСР-3620/29.05.2014 |
02.07.2014 |
08.09.2012 |
|
Заличен |
2360 |
| N06AX16 |
Venlafaxine |
Efexiva XR |
Prolonged release capsule, hard |
150 |
mg |
30 |
Sandoz d.d., Словения |
100 |
mg |
- |
13.56 |
0.15578 |
7.01 |
50% |
3.51 |
|
F31.3,F31.4,F31.5,F31.6,F31.7,F33.0,F33.1,F33.2,F33.3,F33.4 |
КЦРР-2078/24.01.2013 г..; НСР-2111/11.12.2013 |
16.01.2014 |
|
|
Заличен |
1565 |
| N06AX16 |
Venlafaxine |
Efexiva XR |
Prolonged release capsule, hard |
75 |
mg |
30 |
Sandoz d.d., Словения |
100 |
mg |
- |
8.7 |
0.15578 |
3.51 |
50% |
1.75 |
|
F31.3,F31.4,F31.5,F31.6,F31.7,F33.0,F33.1,F33.2,F33.3,F33.4 |
КЦРР-2077/24.01.2013 г.; НСР-2110/11.12.2013 |
16.01.2014 |
|
|
Заличен |
2786 |
| N06AX16 |
Venlafaxine |
Elify XR |
prolonged‐release capsule, hard |
150 |
mg |
30 |
Medochemie Ltd., Кипър |
100 |
mg |
- |
18.71 |
0.15578 |
7.01 |
50% |
3.51 |
|
F31.3,F31.4,F31.5,F31.6,F31.7,F33.0,F33.1,F33.2,F33.3,F33.4 |
КЦРР-210/27.02.2012 г.; HCР-521/11.07.2013; НСР-3149/26.03.2014 |
16.04.2014 |
08.09.2012 |
|
Заличен |
1972 |
| N06AX16 |
Venlafaxine |
ELIFY XR |
Prolonged release capsule, hard |
75 |
mg |
30 |
Medochemie Ltd., Кипър |
100 |
mg |
- |
8.1 |
0.35256 |
7.93 |
50% |
3.96 |
|
F31.3,F31.4,F31.5,F31.6,F31.7,F33.0,F33.1,F33.2,F33.3,F33.4 |
КЦРР-210/27.02.2012 г.; HCР-522/11.07.2013; НСР-7710/17.12.2015; НСР-18287/28.03.2019 |
02.05.2019 |
08.09.2012 |
|
Активен |
1971 |
| N06AX16 |
Venlafaxine |
IVRIX |
Tablet |
75 |
mg |
60 |
Неола Фарма ЕООД, България |
100 |
mg |
- |
29.1 |
0.15578 |
7.01 |
50% |
3.51 |
|
F31.3,F31.4,F31.5,F31.6,F31.7,F33.0,F33.1,F33.2,F33.3,F33.4 |
№ 204/ 24.10.2011; НСР-4790/13.10.2014 .; НСР-6746/16.07.2015. |
16.08.2015 |
08.09.2012 |
|
Заличен |
1097 |
| N06AX16 |
Venlafaxine |
IVRIX |
Tablet |
37.5 |
mg |
60 |
Неола Фарма ЕООД, България |
100 |
mg |
- |
14.57 |
0.15578 |
3.51 |
50% |
1.75 |
|
F31.3,F31.4,F31.5,F31.6,F31.7,F33.0,F33.1,F33.2,F33.3,F33.4 |
№ 204/ 24.10.2011; НСР-4791/13.10.2014.; НСР-6745/16.07.2015. |
16.08.2015 |
08.09.2012 |
|
Заличен |
1096 |
| N06AX16 |
Venlafaxine |
Lanvexin |
Prolonged release capsule, hard |
150 |
mg |
60 |
G. L. Pharma GmbH, Австрия |
100 |
mg |
- |
31.73 |
0.35256 |
31.73 |
50% |
15.86 |
|
F31.3,F31.4,F31.5,F31.6,F31.7,F33.0,F33.1,F33.2,F33.3,F33.4 |
НСР-11955/10.03.2017 |
02.11.2018 |
|
|
Активен |
15624 |
| N06AX16 |
Venlafaxine |
Lanvexin |
Prolonged release capsule, hard |
150 |
mg |
30 |
G. L. Pharma GmbH, Австрия |
100 |
mg |
- |
10.88 |
0.24178 |
10.88 |
50% |
5.44 |
|
F31.3,F31.4,F31.5,F31.6,F31.7,F33.0,F33.1,F33.2,F33.3,F33.4 |
№20/15.07.2009; №130/ 20.12.2010; КЦРР-2204/06.02.2013 г.; КП-127/27.12.2016 и НСР-9550/17.06.2016; НСР-16831/20.09.2018 |
02.11.2018 |
08.09.2012 |
|
Заличен |
1743 |
| N06AX16 |
Venlafaxine |
Lanvexin |
Prolonged release capsule, hard |
75 |
mg |
30 |
G. L. Pharma GmbH, Австрия |
100 |
mg |
- |
8.7 |
0.35256 |
7.93 |
50% |
3.96 |
|
F31.3,F31.4,F31.5,F31.6,F31.7,F33.0,F33.1,F33.2,F33.3,F33.4 |
№20/15,07,2009; №130/ 20.12.2010; КЦРР-2204/06.02.2013 г.; НСР-3993/30.06.2014 |
02.11.2018 |
08.09.2012 |
|
Активен |
3033 |
| N06AX16 |
Venlafaxine |
LAROXIN SR |
Prolonged release capsule, hard |
75 |
mg |
30 |
Actavis Group PTC ehf., Исландия |
100 |
mg |
- |
13.69 |
0.35256 |
7.93 |
50% |
3.96 |
|
F31.3,F31.4,F31.5,F31.6,F31.7,F33.0,F33.1,F33.2,F33.3,F33.4 |
КЦРР-2171/06.02.2013 г.; НСР-18467/22.04.2019 |
02.06.2019 |
|
|
Активен |
1596 |
| N06AX16 |
Venlafaxine |
LAROXIN SR |
Prolonged release capsule, hard |
150 |
mg |
30 |
Actavis Group PTC ehf., Исландия |
100 |
mg |
- |
17.87 |
0.35256 |
15.87 |
50% |
7.93 |
|
F31.3,F31.4,F31.5,F31.6,F31.7,F33.0,F33.1,F33.2,F33.3,F33.4 |
КЦРР-2171/06.02.2013 г. |
02.11.2018 |
|
|
Активен |
1597 |
| N06AX16 |
Venlafaxine |
LAROXIN SR |
Prolonged release tablet |
75 |
mg |
30 |
Актавис EАД, България |
100 |
mg |
- |
17.21 |
0.15578 |
3.51 |
50% |
1.75 |
|
F31.3,F31.4,F31.5,F31.6,F31.7,F33.0,F33.1,F33.2,F33.3,F33.4 |
НСР-3093/21.03.2014 |
16.04.2014 |
08.09.2012 |
|
Заличен |
474 |
| N06AX16 |
Venlafaxine |
LAROXIN SR |
Prolonged release tablet |
150 |
mg |
30 |
Актавис EАД, България |
100 |
mg |
- |
34.45 |
0.15578 |
7.01 |
50% |
3.51 |
|
F31.3,F31.4,F31.5,F31.6,F31.7,F33.0,F33.1,F33.2,F33.3,F33.4 |
НСР-3094/21.03.2014 |
16.04.2014 |
08.09.2012 |
|
Заличен |
473 |
| N06AX16 |
Venlafaxine |
Tifaxin MR |
Prolonged release capsule, hard |
75 |
mg |
30 |
Stada Arzneimittel AG, Германия |
100 |
mg |
- |
10.88 |
0.35256 |
7.93 |
50% |
3.96 |
|
F31.3,F31.4,F31.5,F31.6,F31.7,F33.0,F33.1,F33.2,F33.3,F33.4 |
НСР-16955/12.10.2018 |
02.11.2018 |
|
|
Активен |
16310 |
| N06AX16 |
Venlafaxine |
TIFAXIN SR |
Prolonged release capsule, hard |
75 |
mg |
30 |
Stada Arzneimittel AG, Германия |
100 |
mg |
- |
11.63 |
0.35256 |
7.93 |
50% |
3.96 |
|
F31.3,F31.4,F31.5,F31.6,F31.7,F33.0,F33.1,F33.2,F33.3,F33.4 |
№100/23.08.2010; НСР-2322/13.01.2014; НСР-5807/12.03.2015 |
02.11.2018 |
08.09.2012 |
|
Активен |
3682 |